Ovarian and Fallopian Tubr Tumors Flashcards
MCC of gynecologic DEATH
Ovarian carcinoma
65% of all ovarian tumors and 95 % of all ovarian cancers are
EPITHELIAL TUMORS
5% to 10% of ovarian cancer is metastatic from other primary tumors in the body
GIT - Krukenberg tumor
breast
endometrium
WHO Classification - Ovarian Cancer
EPITHELIAL (65%)
Serous Mucinous Endometrioid Clear cell (Mesonephroid) Brenner)
WHO Classification - Ovarian Cancer
SEX CORD < 0.01
Granulosa cell
Thecoma-fibroma
Sertoli-Leydig
WHO Classification - Ovarian Cancer
GERM CELL (6%)
Primitive (Dysgerminoma, Yolk Sac)
Teratoma
WHO Classification - Ovarian Cancer
GERM CELL SEX CORD (<0.01)
Gonadoblastoma
WHO Classification - Ovarian Cancer
MISCELLANEOUS
Tumors of rete ovarii
Small cell ca
Large cell ca
Wilms tumor
Risk Factors for Ovarian Cancer
Familial ovarian ca Family hx of breast and/or ovarian ca Personal hx of breast ca Increasing age Early menarche (<12) Infertility Nulliparity Late onset menopause (> 50) Obesity (BMI > 30)
Protective Factors for Ovarian Cancer
Use of OCPs (> 5 years) Multiparity Breastfeeding Tubal ligation Hysterectomy
Symptoms of Ovarian Cancer
bloating, early satiety, dyspepsia, abdominal pain, pelvic pain
back pain, urinary frequency/urgency
constipation, fatigue, dyspareunia, menstrual changes
The PRIMARY DIAGNOSTIC TOOL for investigating an adnexal mass
Pelvic Ultrasound
The MC MALIGNANT epithelial cell tumors
The MC type of epithelial ovarian cancer
Serous Cystadenocarcinomas
large, cystic, bilateral
Elevated in 80% of epithelial cell cancers
Useful in tracking the effect of treatment and recurrence of epithelial ovarian ca
CA 125
Mainstay of treatment of epithelial cell tumors
SURGERY TAHBSO omentectomy cytoreduction or debulking bilateral pelvic and paraaortic lymph node sampling
Treatment AFTER surgery of epithelial ovarian cancer
COMBINATION CHEMOTHERAPY
IV Carboplatin, Paclitacel or Docetaxel
The most commonly used to evaluate the success of treatment to diagnose recurrent disease
CA 125 and CT scan
Treatment for recurrent or persistent cancer
Chemotherapy
Overall 5 year survival rate of ovarian cancer
20%
Stage I - 80-95%
Stage II - 40-70%
Stage III - 30%
Stage IV - <10%
Transitional cell tumor
“coffee bean” appearing nucleus
Solid mass or nests of epithelial cells and a surrounding fibrous stroma
Brenner Tumor
Dermoid cysts/Mature teratoma
80% occur in reproductive life
MC neoplasm in prepubertal female
Benign Cystic Teratoma
MC BENIGN solid tumor of the ovary
Extremely slow growing and unilateral
Whorled pattern
Fibroma
MEIG’S SYNDROME
- ovarian fibroma
- ascites
- hydrothorax
Epithelial cells filled with mucin
Resembles endocervix/GIT
Mucinous tumor
Contains cell with abundant glycogen (HOBNAIL CELLS)
Associated with DES exposure
Clear Cell